Assessing vaccine safety during a pandemic: Recent experience and lessons learned for the future.
Journal Information
Full Title: Vaccine
Abbreviation: Vaccine
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Allergy and Immunology
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. KME receives grant funding from the NIH to mentor young investigators and from the CDC to monitor vaccine safety. She is a consultant to Bionet and IBM and a member of Data Safety and Monitoring Boards for Sanofi, X-4 Pharma, Seqirus, Moderna, Pfizer, Merck, Roche, Novavax, and CEPI. MS is head of a department that conducts vaccine safety studies for the European Medicines Agency, AstraZeneca, Pfizer and Janssen. SBB is a consultant to GSK for program planning, receives funding from CEPI and grant funding from the US CDC."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025